יירבוי 5 מגמל Israel - Tiếng Do Thái - Ministry of Health

יירבוי 5 מגמל

bristol, myers squibb (israel) limited, israel - ipilimumab - תרכיז להכנת תמיסה לאינפוזיה - ipilimumab 5 mg/ml - ipilimumab - ipilimumab - yervoy (ipilimumab) is indicated for the treatment of unresectable or metastatic melanoma.

סטיוורגה Israel - Tiếng Do Thái - Ministry of Health

סטיוורגה

bayer israel ltd - regorafenib - טבליות מצופות פילם - regorafenib 40 mg - regorafenib - regorafenib - stivarga is indicated for the treatment of patients with metastatic colorectal cancer (crc) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-vegf therapy, and if kras wild-type, an anti-egfr therapy.for the treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumors (gist) who have been previously treated with imatinib mesylate and sunitinib malate

אקסג'יבה Israel - Tiếng Do Thái - Ministry of Health

אקסג'יבה

amgen europe b.v. - denosumab - תמיסה להזרקה - denosumab 120 mg / 1.7 ml - denosumab - denosumab - prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumours.

סימביקורט טורבוהלר 804.5 מקגמנה Israel - Tiếng Do Thái - Ministry of Health

סימביקורט טורבוהלר 804.5 מקגמנה

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 80 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. note: symbicort turbuhaler 80/4.5 mcg/dose is not appropriate in patients with severe asthma.

סימביקורט טורבוהלר 1604.5 מקגמנה Israel - Tiếng Do Thái - Ministry of Health

סימביקורט טורבוהלר 1604.5 מקגמנה

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 160 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - asthma symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents age 12 years and above where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. or - patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

סימביקורט טורבוהלר 3209  מקגמנה Israel - Tiếng Do Thái - Ministry of Health

סימביקורט טורבוהלר 3209 מקגמנה

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 320 mcg/dose; formoterol fumarate 9 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents (over the age of 12 years) where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

פולמוקאר וניל Israel - Tiếng Do Thái - Ministry of Health

פולמוקאר וניל

abbott medical laboratories ltd - acid casein 5.8 g / 100 ml; ascorbic acid 77.4 mg / 100 ml - liquid - fat/carbohydrates/proteins/minerals/vitamins, combinations - theraputic nutrition for people with copd (chronic obstructive pulmonary disease). ahigh calorie low carbohydrate formula specifically dasigned to help reduce carbon dioxide producton.

אנשור פלוס בטעם וניל ותות Israel - Tiếng Do Thái - Ministry of Health

אנשור פלוס בטעם וניל ותות

abbott medical laboratories ltd - acid casein 4.4 g / 100 ml; ascorbic acid 35.3 mg / 100 ml - liquid - fat/carbohydrates/proteins/minerals/vitamins, combinations - for complete and balanced oral nutritional supplement that can be used with or between meals or in appropriate amounts, as a meal replacement.

ג'ביטי (מזון נוזלי מוכן עם סיבים) Israel - Tiếng Do Thái - Ministry of Health

ג'ביטי (מזון נוזלי מוכן עם סיבים)

abbott medical laboratories ltd - acid casein 4 g / 100 ml; ascorbic acid 51.2 mg / 100 ml - liquid - fat/carbohydrates/proteins/minerals/vitamins, combinations - isotonic liquid food with fiber that provides complete balanced nutrition, for those requiring long-term tube feeding and for oral feeding.

אנשור נוזל בטעם וניל Israel - Tiếng Do Thái - Ministry of Health

אנשור נוזל בטעם וניל

abbott medical laboratories ltd - ascorbic acid 13 mg / 100 ml; biotin 32 mcg / 100 ml - liquid - fat/carbohydrates/proteins/minerals/vitamins, combinations - complete balance nutrition for diets or supplementation for those requiring unordinary feeding.